Journalist Hunt

JournalistsPricingBlogs

Farhad Ravandi - Profile and Journalist Details

Find journalists that align with your industry, location and vision. Unlock Farhad Ravandi's full journalist profile, including location, coverage topics, current employer, biography and preferences. Sign up today and start building journalist relationships that fuel your startup's growth.

Get connected with journalists today
Farhad Ravandi

Farhad Ravandi

Verified

Editorial Board Member, Blood Cancer Journal

Beats

Primary beats

ScienceHealth

Secondary beats

Entertainment and filmLuxuryHumorVisual CommunicationWomanhoodMental HealthHealthcareFood and travelPublic Health InitiativesFood and DiningSeafood and fishingOrganic ContentChicago

Final Covers

Health, Politics, Current Events , Drawing, Art, Science , Photography

Doesn’t Cover

I do not cover topics, which exploit or bring harm to anyone or communities.

Journalist Type

Editor

Seniority Positions

Editorial Board Member

Industries

-

Medium Formats

Blood Cancer Journal

Content

Total articles 62

  • Reduced venetoclax exposure to 7 days vs standard exposure with hypomethylating agents in newly diagnosed AML patients - Blood Cancer Journal

    By Christophe Willekens, Alex Bataller, Caitlin R Rausch, Nicholas Short, Koji Sasaki, Mahesh Swaminathan, Jean-Baptiste Micol, Tapan M Kadia, Farhad Ravandi, Arnaud Pagès, Hagop Kantarjian · Nature

    Apr. 16, 2025

  • Barriers to allogeneic stem cell transplantation in responding patients with TP53-mutated acute myeloid leukemia - Bone Marrow Transplantation

    By Jayastu Senapati, Guillermo Garcia-Manero, Courtney DiNardo, Gautam Borthakur, Tapan M Kadia, Elias Jabbour, Nicholas Short, Hussein Abbas, Naveen Pemmaraju, Uday Popat, Sanam Loghavi, Guilin Tang, Farhad Ravandi, Hagop Kantarjian · Nature

    Apr. 10, 2025

As seen in

Cancer,Blood Cancer Journal,Expert Review Of Anticancer Therapy,The Asco Post,Nature,Texas Medical Center,Wiley Online Library,Oncology Times,Jama Oncology,Future Medicine,Medscape,The Lancet

Company Info

Blood Cancer Journal

Hoboken, New Jersey, United States

'+1 201-748-6000